FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to a local pharmaceutical composition for treating alopecia, methods of treating alopecia, using a local pharmaceutical composition for treating alopecia. Local pharmaceutical composition for treating alopecia contains fully solubilized cortexolone-17α-propionate in concentration of 2.1–7.5 wt % and one or more pharmaceutically acceptable solvents, methods of treating alopecia include applying a local pharmaceutical composition to a subject.
EFFECT: group of inventions provides a stable pharmaceutical composition containing cortexolone-17α-propionate, for treating alopecia, with optimum local delivery of the therapeutic agent and minimizing the systemic effect of cortexolone-17α-propionate.
70 cl, 2 dwg, 21 tbl, 11 ex
